Gender Representation in Trials
- 29 September 2000
- journal article
- Published by Elsevier in Controlled Clinical Trials
- Vol. 21 (5), 462-475
- https://doi.org/10.1016/s0197-2456(00)00086-6
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- FDA Policy on Women in Drug TrialsNew England Journal of Medicine, 1993
- Women in Clinical Trials of New Drugs -- A Change in Food and Drug Administration PolicyNew England Journal of Medicine, 1993
- A randomized trial of aspirin and β-carotene among U.S. physiciansPreventive Medicine, 1985
- The Lipid Research Clinics Coronary Primary Prevention Trial ResultsJAMA, 1984
- Multiple Risk Factor Intervention TrialJAMA, 1982
- Statistical design considerations in the NHLI multiple risk factor intervention trial (MRFIT)Journal of Chronic Diseases, 1977
- Clofibrate and niacin in coronary heart diseaseJAMA, 1975
- The Coronary Drug Project. Findings leading to discontinuation of the 2.5-mg day estrogen group. The coronary Drug Project Research GroupPublished by American Medical Association (AMA) ,1973
- The coronary drug project. Findings leading to further modifications of its protocol with respect to dextrothyroxine. The coronary drug project research groupPublished by American Medical Association (AMA) ,1972
- The Coronary Drug ProjectPublished by American Medical Association (AMA) ,1970